Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
CCR4-bearing T cells participate in autoimmune diabetes
Soon H. Kim, … , David Chantry, Nora Sarvetnick
Soon H. Kim, … , David Chantry, Nora Sarvetnick
Published December 1, 2002
Citation Information: J Clin Invest. 2002;110(11):1675-1686. https://doi.org/10.1172/JCI15547.
View: Text | PDF
Article Immunology

CCR4-bearing T cells participate in autoimmune diabetes

  • Text
  • PDF
Abstract

Research Article

Authors

Soon H. Kim, Mary M. Cleary, Howard S. Fox, David Chantry, Nora Sarvetnick

×

Figure 8

Options: View larger image (or click on image) Download as PowerPoint
MDC-mediated acceleration of disease. (a) Acceleration of diabetes in MD...
MDC-mediated acceleration of disease. (a) Acceleration of diabetes in MDC-TG NOD mice. Diabetogenic potential was compared after adoptive transfer of splenocytes from (b) 8-week-old prediabetic (n = 3) or (c) 16- to 18-week-old diabetic (n = 3) MDC-TG and non-TG littermates into 8- to 10-week-old NOD-scid female recipients. Open circles, non-TG NOD littermates; filled circles, MDC-TG NOD mice. (d) MDC-mediated Th1 immune response. Splenocytes from 11-week-old MDC-TG and non-TG NOD females (three mice/group) were stimulated with the islet antigen, GAD65, presented by irradiated spleen cells as APCs. Culture supernatants were analyzed for cytokine secretion by ELISA. T cell proliferation was measured in response to GAD65 presented by APCs (e) or upon stimulation of costimulatory factors such as CD3/CD28 (f). Bars represent mean values ± SEM from two separate experiments. White bars and open circles, non-TG littermates. Black bars and filled circles, MDC-TG NOD females.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts